[go: up one dir, main page]

PL3600278T3 - Statyna w profilaktyce/ograniczaniu uszkodzeń związanych z niedokrwieniem - Google Patents

Statyna w profilaktyce/ograniczaniu uszkodzeń związanych z niedokrwieniem

Info

Publication number
PL3600278T3
PL3600278T3 PL18715625T PL18715625T PL3600278T3 PL 3600278 T3 PL3600278 T3 PL 3600278T3 PL 18715625 T PL18715625 T PL 18715625T PL 18715625 T PL18715625 T PL 18715625T PL 3600278 T3 PL3600278 T3 PL 3600278T3
Authority
PL
Poland
Prior art keywords
hyphenotomy
statins
prevention
damage
reduction
Prior art date
Application number
PL18715625T
Other languages
English (en)
Inventor
Lina Badimon Maestro
Gemma VILAHUR GARCIA
Original Assignee
Fundació Institut De Recerca De L'hospital De La Santa Creu I Sant Pau
Gendiag, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP17164137.6A external-priority patent/EP3381452A1/en
Application filed by Fundació Institut De Recerca De L'hospital De La Santa Creu I Sant Pau, Gendiag, S.L. filed Critical Fundació Institut De Recerca De L'hospital De La Santa Creu I Sant Pau
Publication of PL3600278T3 publication Critical patent/PL3600278T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18715625T 2017-03-31 2018-03-29 Statyna w profilaktyce/ograniczaniu uszkodzeń związanych z niedokrwieniem PL3600278T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17164137.6A EP3381452A1 (en) 2017-03-31 2017-03-31 Statin for prevention/reduction of ischemia-related damage
ES201730736 2017-05-26
EP18715625.2A EP3600278B1 (en) 2017-03-31 2018-03-29 Statin for prevention/reduction of ischemia-related damage
PCT/EP2018/058158 WO2018178275A1 (en) 2017-03-31 2018-03-29 Statin for prevention/reduction of ischemia-related damage

Publications (1)

Publication Number Publication Date
PL3600278T3 true PL3600278T3 (pl) 2021-08-02

Family

ID=61899251

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18715625T PL3600278T3 (pl) 2017-03-31 2018-03-29 Statyna w profilaktyce/ograniczaniu uszkodzeń związanych z niedokrwieniem

Country Status (11)

Country Link
US (1) US20200030288A1 (pl)
EP (1) EP3600278B1 (pl)
CN (1) CN110494134A (pl)
BR (1) BR112019020353A2 (pl)
CA (1) CA3058250A1 (pl)
DK (1) DK3600278T3 (pl)
ES (1) ES2877646T3 (pl)
MX (1) MX388159B (pl)
PL (1) PL3600278T3 (pl)
RU (1) RU2768889C2 (pl)
WO (1) WO2018178275A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112516126A (zh) * 2020-11-20 2021-03-19 南方医科大学南方医院 普伐他汀的新用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9264598A (en) 1997-08-22 1999-03-16 Gist-Brocades B.V. Statin production by fermentation
PL374126A1 (pl) * 2002-05-17 2005-10-03 Esperion Therapeutics, Inc. Sposoby i kompozycje do leczenia reperfuzji niedokrwiennej
US7166638B2 (en) 2003-05-27 2007-01-23 Nicox S.A. Statin derivatives
CN100502870C (zh) * 2005-07-07 2009-06-24 安徽省现代中药研究中心 含有瑞舒伐他汀或匹伐他汀和b族维生素的药物组合物
AU2007209859A1 (en) * 2006-01-30 2007-08-09 Israel Ben David Bryson Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients
US8183397B2 (en) 2007-04-03 2012-05-22 Lek Pharmaceuticals D.D. Synthesis of statins
EP2271335A1 (en) 2008-04-29 2011-01-12 DSM IP Assets B.V. Improved statin production
CN102171328A (zh) 2008-09-24 2011-08-31 帝斯曼知识产权资产管理有限公司 经改进的斯达汀生产
US10028975B2 (en) * 2010-10-19 2018-07-24 Beth Israel Deaconess Medical Center, Inc. Methods for treating ischemia-reperfusion injury
EP2949324A1 (en) * 2014-05-27 2015-12-02 Consorci Institut Catala de Ciencies Cardiovasculars Prevention and/or treatment of ischemia/reperfusion injury

Also Published As

Publication number Publication date
MX2019011567A (es) 2020-01-21
EP3600278A1 (en) 2020-02-05
EP3600278B1 (en) 2021-01-27
CN110494134A (zh) 2019-11-22
RU2019134491A (ru) 2021-04-30
DK3600278T3 (da) 2021-04-26
BR112019020353A2 (pt) 2020-04-28
RU2768889C2 (ru) 2022-03-25
ES2877646T3 (es) 2021-11-17
US20200030288A1 (en) 2020-01-30
MX388159B (es) 2025-03-19
WO2018178275A1 (en) 2018-10-04
RU2019134491A3 (pl) 2021-07-16
CA3058250A1 (en) 2018-10-04

Similar Documents

Publication Publication Date Title
IL293377A (en) Hsd17b13 variants and uses thereof
IL285686B (en) Crystalline solid forms of a bet inhibitor
PL3625759T3 (pl) Redukcja szumów w obrazie
DK3497103T3 (da) Pyridopyrimdinon-cdk2/4/6-inhibitorer
IL255364A0 (en) Malware warning
IL280863A (en) Autotaxin inhibitors and uses thereof
EP3626699A4 (en) SSAO INHIBITOR
HUE055139T2 (hu) A SIRP-alfa domént vagy ennek variánsát tartalmazó készítmények
DK3571192T3 (da) Jak1-selektive inhibitorer
CL2018000700A1 (es) Sililfenoxiheterociclos trisustituidos y análogos
DK3672948T3 (da) Pyridinamin-pyridon- og pyrimidinamin-pyridonforbindelser
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
MA49006A (fr) Inhibiteurs d'ip6k
DK3630744T3 (da) Pyrazol-magl-inhibitorer
MA49905A (fr) Polyesteramines et polyesterquats
DK3362817T3 (da) Multimission- og multispektral sonar
EP3689808A4 (en) CRANE
EP3640194A4 (en) CRANE
EP3594165A4 (en) CRANE
IT201700075652A1 (it) Contenitore e procedimento di realizzazione dello stesso
EP3730446A4 (en) CRANE
DK3672967T3 (da) Azaindolylpyridon- og diazaindolylpyridonforbindelser
EP3528810A4 (en) BROMDOMAIN INHIBITOR
EP3564533A4 (en) Compressor and vehicle
PL3600278T3 (pl) Statyna w profilaktyce/ograniczaniu uszkodzeń związanych z niedokrwieniem